Twist Stock Today


USD 51.72  2.19  4.06%   

Market Performance
11 of 100
Odds Of Distress
Less than 20
Twist Bioscience is selling for under 51.72 as of the 16th of August 2022; that is -4.06 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 49.33. Twist Bioscience has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Twist Bioscience Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of July 2022 and ending today, the 16th of August 2022. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
31st of October 2018
Health Care
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 49.63 M outstanding shares of which 6.66 M shares are at this time shorted by private and institutional investors with about 5.07 trading days to cover. More on Twist Bioscience Corp

Moving together with Twist Bioscience

0.61AAgilent Technologies Earnings Call  TodayPairCorr
0.76IDXXIdexx Laboratories Sell-off TrendPairCorr
0.81AAPLApple Inc Fiscal Year End 27th of October 2022 PairCorr

Twist Bioscience Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Twist Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Twist Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Twist Bioscience is way too risky over 90 days horizon
Twist Bioscience appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 163.11 M. Net Loss for the year was (187.51 M) with profit before overhead, payroll, taxes, and interest of 51.71 M.
Twist Bioscience Corp currently holds about 573.86 M in cash with (151.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.2.
Twist Bioscience has a frail financial position based on the latest SEC disclosures
Latest headline from TWIST BIOSCIENCE CORP Managements discussion and analysis of financial condition and results of operations -
President CEO, DirectorEmily Leproust
Average Analyst Recommendation
Analysts covering Twist Bioscience report their recommendations after researching Twist Bioscience's financial statements, talking to executives and customers, or listening in on Twist Bioscience's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Twist Bioscience Corp. The Twist consensus assessment is calculated by taking the average forecast from all of the analysts covering Twist Bioscience.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Twist Bioscience Corp based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Twist Bioscience Corp financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares46.9 M43.4 M
Significantly Up
Slightly volatile
Weighted Average Shares Diluted46.9 M43.4 M
Significantly Up
Slightly volatile
Total Assets681.8 M631.9 M
Significantly Up
Slightly volatile
Total Liabilities117.8 M109.1 M
Significantly Up
Slightly volatile
Current Assets530.7 M491.8 M
Significantly Up
Slightly volatile
Current Liabilities61.2 M56.7 M
Significantly Up
Slightly volatile
Gross Margin37.9535.17
Significantly Up
Slightly volatile
Asset Turnover0.230.22
Sufficiently Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Twist Bioscience's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Twist Bioscience Corp (TWST) is traded on NASDAQ Exchange in USA and employs 652 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Twist Bioscience's market, we take the total number of its shares issued and multiply it by Twist Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Twist Bioscience Corp conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 49.63 M outstanding shares of which 6.66 M shares are at this time shorted by private and institutional investors with about 5.07 trading days to cover. Twist Bioscience Corp currently holds about 573.86 M in cash with (151.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.2.
Check Twist Bioscience Probability Of Bankruptcy
Twist Bioscience maintains a total of 49.63 Million outstanding shares. The majority of Twist Bioscience Corp outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Twist Bioscience to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Twist Bioscience Corp. Please pay attention to any change in the institutional holdings of Twist Bioscience Corp as this could imply that something significant has changed or about to change at the company. Also note that roughly six million nine hundred fourty-eight thousand two hundred invesors are currently shorting Twist Bioscience expressing very little confidence in its future performance.

Ownership Allocation (%)

Check Twist Ownership Details

Twist Stock Price Odds Analysis

What are Twist Bioscience's target price odds to finish over the current price? Attributed to a normal probability distribution, the odds of Twist Bioscience jumping above the current price in 90 days from now is under 4%. The Twist Bioscience Corp probability density function shows the probability of Twist Bioscience stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.1396. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Twist Bioscience will likely underperform. Moreover, the company has an alpha of 1.0517, implying that it can generate a 1.05 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 51.72HorizonTargetOdds Above 51.72
96.26%90 days
Based on a normal probability distribution, the odds of Twist Bioscience to move above the current price in 90 days from now is under 4 (This Twist Bioscience Corp probability density function shows the probability of Twist Stock to fall within a particular range of prices over 90 days) .

Twist Bioscience Historical Income Statement

Twist Bioscience Corp Income Statement is one of the three primary financial statements used for reporting Twist's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Twist Bioscience Corp revenue and expense. Twist Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Twist Bioscience Direct Expenses is comparatively stable at the moment as compared to the past year. Twist Bioscience reported Direct Expenses of 72.56 Million in 2021. Revenues is likely to gain to about 128.5 M in 2022, whereas Net Income is likely to drop (188.7 M) in 2022. View More Fundamentals

Twist Stock Against Markets

Picking the right benchmark for Twist Bioscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Twist Bioscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Twist Bioscience is critical whether you are bullish or bearish towards Twist Bioscience Corp at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Twist Bioscience without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now


Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Twist Bioscience Corporate Directors

Twist Bioscience corporate directors refer to members of a Twist Bioscience board of directors. The board of directors generally takes responsibility for the Twist Bioscience's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Twist Bioscience's board members must vote for the resolution. The Twist Bioscience board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Frederick Craves - DirectorProfile
Robert Chess - Lead Independent DirectorProfile
William Banyai - COO, DirectorProfile
Mai Xiaoying - DirectorProfile

Invested in Twist Bioscience Corp?

You need to understand the risk of investing before taking a position in Twist Bioscience. The danger of trading Twist Bioscience Corp is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Twist Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Twist Bioscience. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Twist Bioscience Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. Note that the Twist Bioscience Corp information on this page should be used as a complementary analysis to other Twist Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.